Tag: Contract Development and Manufacturing Organization
Bioconjugation Technology Selection during Early-Stage Development – A Strategy to Streamline...
Abstract
Bioconjugate therapeutics comprise a fast-growing class of drugs with applications in various disease areas. In the past years, particularly antibody-drug conjugates (ADCs) have undergone...
A New Horizon in ADC Technology: A Panel Discussion
Targeted therapies such as antibody-drug conjugates (ADC) have opened new ways in targeting diseases like cancer and hematological malignancies. High-potent active pharmaceutical ingredients, also...
Rapidly Expanding MabPlex International Secures U.S. $ 59.1 Million Series A...
In an announcement made to the international business and financial press, MabPlex International, a global Contract Development and Manufacturing Organization or CDMO based in...
